| Literature DB >> 28032063 |
Hamid Karyab1, Masud Yunesian2, Simin Nasseri2, Noushin Rastkari2, Amirhosein Mahvi2, Ramin Nabizadeh2.
Abstract
BACKGROUND: This study was focused on the probability of carcinogen risk of low-level ingestion and dermal exposure with polycyclic aromatic hydrocarbons (PAHs) from drinking water in Tehran, capital of Iran.Entities:
Keywords: Drinking water; Iran; Risk assessment; Uncertainties
Year: 2016 PMID: 28032063 PMCID: PMC5182254
Source DB: PubMed Journal: Iran J Public Health ISSN: 2251-6085 Impact factor: 1.429
Concentration of Benzo (a) Pyrene equivalent in different water sources (ng/L)
| Max. | 107.20 | 68.11 | 25.71 | 65.69 | 23.72 | 20.10 | 30.8 | 7.78 | 14.2 | 2.33 |
| Min. | 1.96 | 3.29 | 3.27 | 1.13 | 3.24 | 3.10 | 3.41 | 3.41 | 3.41 | 0.11 |
| Mean | 29.44 | 21.55 | 11.67 | 19.43 | 11.56 | 12.00 | 5.08 | 4.35 | 4.84 | 0.45 |
| Median | 4.30 | 7.41 | 8.85 | 5.45 | 9.64 | 12.41 | 3.42 | 3.55 | 3.50 | 0.18 |
Exposure parameters of ingestion and dermal exposure to PAHs in the different exposure pathway (mean ± SD)
| Direct water ingestion | Tap | L/capita/day | 0.45±0.12 | 0.51±0.14 | 1.12±0.27 | 1.23±0.27 |
| Bottled | 0.22±0.06 | 0.29±0.06 | 0.27±0.10 | 0.30±0.15 | ||
| Heated | 0.28±0.12 | 0.27±0.06 | 0.38±0.13 | 0.54±0.14 | ||
| Dermal exposure | Washing | Event/day | 2.97±1.03 | 2.84±0.49 | 3.04±0.73 | 3.89±1.13 |
| Showering | 3.27±0.47 | 2.67±0.44 | 2.85±0.63 | 2.72±1.03 | ||
| Swimming | ND | ND | 0.03±0.12 | 0.10±0.38 | ||
| Dermal exposure | Washing | Min/event | 1.24±0.81 | 1.77±0.77 | 1.71±0.48 | 1.73±0.73 |
| Showering | 17.36±8.72 | 24.20±8.53 | 26.64±7.68 | 27.02±9.49 | ||
| Swimming | ND | ND | 90 | 58.15±15.29 | ||
Not determined
Lifetime average daily dose and dermal adsorb dose if ingestion and dermal exposure to PAHs from drinking water (mg/kg/d)
| Ingestion | Tap water | 8 -10×2.93 | 8 -10×6.64 | 8 -10×3.46 | 7 -10×4.63 | 7 -10×6.37 |
| Bottled water | 9 -10×4.38 | 8 -10×1.15 | 9 -10×5.76 | 8 -10×3.46 | 8 -10×5.62 | |
| Heated water | 10 -10×2.35 | 10 -10×4.44 | 10 -10×3.35 | 9 -10×2.57 | 9 -10×3.58 | |
| sum | 8 -10×3.39 | 8 -10×7.84 | 8 -10×8.42 | 7 -10×5.01 | 7 -10×6.97 | |
| Dermal | washing | 7 -10×1.13 | 7 -10×2.71 | 7 -10×1.16 | 7 -10×1.56 | 6 -10×2.10 |
| showering | 7 -10×3.98 | 6 -10×1.10 | 6 -10×1.39 | 6 -10×8.39 | 5 -10×1.11 | |
| swimming | ND | ND | 9 -10×6.05 | 7 -10×1.04 | 7 -10×1.09 | |
| sum | 7 -10×5.11 | 6 -10×1.37 | 6 -10×1.55 | 6 -10×9.90 | 5 -10×1.33 |
The estimated ingestion and dermal ELCR for exposure to PAHs in the water sources
| Ingestion | Tap water | 5 -10×0.34 | 5 -10×0.23 | 5 -10×0.35 | 5 -10×0.47 | 5 -10×1.36 |
| Bottled water | 5 -10×0.05 | 5 -10×0.04 | 5 -10×0.02 | 5 -10×0.04 | 5 -10×0.15 | |
| Heated water | 5 -10×0.003 | 5 -10×0.002 | 5 -10×0.001 | 5 -10×0.003 | 5 -10×0.06 | |
| Sum | 5 -10×0.40 | 5 -10×0.28 | 5 -10×0.29 | 5 -10×0.59 | 5 -10×1.57 | |
| Dermal | Washing | 6 -10×1.46 | 6 -10×3.50 | 6 -10×2.08 | 6 -10×2.01 | 5 -10×2.71 |
| Showering | 6 -10×5.15 | 5 -10×1.43 | 5 -10×1.81 | 5 -10×10.7 | 5 -10×14.45 | |
| Swimming | ND | ND | 6 -10×0.08 | 6 -10×1.34 | 5 -10×0.14 | |
| Sum | 5 -10×0.66 | 5 -10×1.78 | 5 -10×2.03 | 5 -10×12.85 | 5 -10×17.24 | |
| Total ELCR | 5 -10×1.06 | 5 -10×2.06 | 5 -10×2.32 | 5 -10×13.44 | 5 -10×18.81 |
Fig. 1:Distriution of excess lifetime cancer risk attributable to direct ingestion of PAHs in drinking water
Fig. 2:Distriution of excess lifetime cancer risk attributable to dermal exposure with PAHs in drinking water
Spearman coefficient of rank correlation for ingestion and dermal excess lifetime cancer risk
| 0.92 | −0.05 | 0.05 | 0.95 | 0.03 | 0.01 | |
| 0.96 | −0.2 | 0.1 | 0.95 | 0.03 | 0.01 | |
| 0.98 | 0.08 | 0.05 | 0.98 | −0.03 | 0.01 | |
| 0.96 | −0.05 | 0.05 | 0.98 | −0.05 | 0.03 | |